Oxford, UK – 29 May 2015: Oxford BioMedica plc (LSE: OXB) (“the Group”), a leading gene and cell therapy group, today announces that John Dawson, Chief Executive Officer of Oxford BioMedica, is scheduled to present at the Jefferies 2015 Global Healthcare Conference to be held in New York on June 1-4, 2015.
The presentation will take place at 4pm EDT / 9pm BST on Tuesday 2nd June. There will be a live audio webcast of the presentation and this can be accessed at http://wsw.com/webcast/jeff88/oxb.l
A PDF copy of the presentation will also be made available on the Oxford BioMedica website. Please follow this link to view this: http://www.oxfordbiomedica.co.uk/corporate-presentations/
Notes to editors
About Oxford BioMedica
Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the "Group") have built a sector leading lentiviral vector delivery platform (LentiVector®), which the Group leverages to develop in vivo and ex vivo products both in-house and with partners. The Group has created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders. The Group has also entered into a number of partnerships, including with Novartis, Bioverativ, Sanofi, Axovant, Orchard Therapeutics, Boehringer Ingelheim/UK Cystic Fibrosis Gene Therapy Consortium/Imperial Innovations, GC LabCell and Immune Design, through which it has long-term economic interests in other potential gene and cell therapy products. Oxford BioMedica is based across several locations in Oxfordshire, UK and employs more than 320 people. Further information is available at www.oxfordbiomedica.co.uk.
For further information please contact
Oxford BioMedica plc
John Dawson, Chief Executive Officer
Stuart Paynter, Chief Financial Officer
Sarah MacLeod, Head of Communications
Tel: +44 (0)1865 783 000
Financial and corporate communications enquiries:
Consilium Strategic Communications
Mary-Jane Elliott/Matthew Neal/Olivia Manser/Laura Thornton
Tel: +44 (0)20 3709 5700